Tyrosine kinase inhibitor interruptions, discontinuations and switching in patients with chronic‐phase chronic myeloid leukemia in routine clinical practice: SIMPLICITY

SIMPLICITY (NCT01244750) is an observational study exploring tyrosine kinase inhibitor (TKI) use and management patterns in patients with chronic phase‐chronic myeloid leukemia in the US and Europe in routine clinical practice. Herein we describe interruptions, discontinuations and switching of TKI...

Descripción completa

Detalles Bibliográficos
Autores principales: Hehlmann, Rüdiger, Cortes, Jorge E., Zyczynski, Teresa, Gambacorti‐Passerini, Carlo, Goldberg, Stuart L., Mauro, Michael J., Michallet, Mauricette, Simonsson, Bengt, Williams, Loretta A., Gajavelli, Srikanth, DeGutis, Irene, Sen, Ginny P., Paquette, Ron L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587733/
https://www.ncbi.nlm.nih.gov/pubmed/30290003
http://dx.doi.org/10.1002/ajh.25306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6587733/
https://www.ncbi.nlm.nih.gov/pubmed/30290003
http://dx.doi.org/10.1002/ajh.25306

Ejemplares similares